The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most...
Vous n'êtes pas connecté
The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most likely to threaten human health with the goal of developing effective vaccines and monoclonal antibodies. Currently, many of the diseases caused by these pathogens have no available vaccines or therapeutics, and investing in this research is key to preparing for potential public health crises-;both in the United States and around the world. NIH's National Institute of Allergy and Infectious Diseases (NIAID) expects to commit approximately $100 million per year to fund the program, pending the availability of funds.
The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most...
Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy and Infectious...
Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy and Infectious...
A new four-year, $3.26 million grant from the National Institute of Neurological Disorders and Stroke (NINDS), a part of the National Institutes of...
Researchers at the Terasaki Institute for Biomedical Innovation have been awarded a multi-million grant from the National Institutes of Health (NIH)...
Researchers at the Terasaki Institute for Biomedical Innovation have been awarded a multi-million grant from the National Institutes of Health (NIH)...
Scientists at the University of Minnesota and the Midwest Antiviral Drug Discovery (AViDD) Center have made a surprising finding about how antibodies...
GENEVA, Switzerland – With the support of the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), the World Health Organization...
Researchers at the National Institutes of Health (NIH) have revealed that carriers of sickle cell disease, known as having sickle cell trait, are at...
An infectious diseases specialist says the spread of mpox in New Zealand can be limited - if people are vigilant and follow public health measures.